TINAVI(SH:688277) Zheng Quan Shi Bao Wang·2025-05-21 12:06Core Viewpoint - Tianzhihang's subsidiary, Anhui Aishirui, is raising funds through a capital increase to promote its rapid development, with a valuation of 150 million yuan before the increase and 210 million yuan after [1][2]. Group 1: Capital Increase Details - Anhui Aishirui plans to introduce five investors, including Guozhong Sanqi Fund and Hefei Economic Development Zone Angel Fund, through a capital increase of 59.8 million yuan for 28.53% equity [1]. - After the capital increase, Tianzhihang's ownership in Anhui Aishirui will decrease from 40.85% to 29.20% [2]. - The capital increase will raise Anhui Aishirui's registered capital to 17.4666 million yuan [1]. Group 2: Financial Performance - As of March 31, 2025, Anhui Aishirui reported total assets of 38.2891 million yuan and net assets of 37.0511 million yuan, with no revenue and a net loss of 2.7489 million yuan for the first quarter of 2025 [1]. - The previous capital increase in December 2024 valued Anhui Aishirui at 120 million yuan, with investors contributing a total of 29.8 million yuan for 19.89% equity [3]. Group 3: Strategic Implications - The capital injection is expected to provide operational funds for Anhui Aishirui, aiding in the development of a core orthopedic surgical robot platform and enhancing the company's competitive edge [2]. - Tianzhihang's decision to waive its preemptive rights for this capital increase aligns with its overall strategic considerations [2].